Jessica Encinas Mayoral, PhD, discusses preclinical data on an AI-designed BCMA/FcRL5 trispecific antibody in multiple myeloma.
Jessica Encinas Mayoral, PhD
Advertisement
Articles by Jessica Encinas Mayoral, PhD
Jessica Encinas Mayoral, PhD, discusses the design and antigen-independent activity of a BCMA/FcRL5 trispecific antibody in multiple myeloma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Belzutifan Plus Lenvatinib for Advanced ccRCC
2
iMMagine-1 vs CARTITUDE-1 MAIC Shows Comparable Efficacy, Improved Safety With Anito-Cel in Relapsed/Refractory Multiple Myeloma
3
Cevostamab Plus Pomalidomide/Dexamethasone Yields Durable, Deep Responses in BCMA-Naive Relapsed/Refractory Myeloma
4
FDA MCGP Panel Vote Backs Galleri Multi-Cancer Early Detection Test
5